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Peroxisome proliferator activated receptors (PPAR)
belong to the superfamily of nuclear hormone receptors
that heterodimerize with the retinoid X receptor and
regulate transcription of several genes involved in lipid
metabolism and adipocyte differentiation. Because of
the role of 1,25-dihydroxyvitamin D3 and retinoic acid
working through similar receptors (the vitamin D recep-
tor and retinoic acid receptor, respectively) on keratino-
cyte differentiation, we have examined the effects of
activators of PPARa on keratinocyte differentiation. The
rate of cornified envelope formation was increased 3-fold
in keratinocytes maintained in low calcium (0.03 mM)
and incubated in the presence of clofibric acid, a potent
PPARa activator. Involucrin, a cornified envelope pre-
cursor, and the cross-linking enzyme transglutaminase,
were increased at both the message level (2–7-fold) and the
protein level (4–12-fold) by clofibric acid. Furthermore,
TThe epidermis is comprised of morphologically distinctcell layers, with each strata representative of a progress-ively more advanced stage of differentiation. As cellsmigrate upward and leave the proliferative basal layer,they lose their capacity to divide and begin to sequentially
express specific proteins (reviewed in Fuchs, 1990): first, keratins K1
and K10, and then proteins such as filaggrin, involucrin (INV), loricrin,
and transglutaminase (TG’ase) 1, specific to later stages of differentiation
(Dale et al, 1985; Eichner et al, 1986; Mehrel et al, 1990; Robinson
et al, 1996). During the final stages of differentiation, TG’ase generates
ε- (γ-glutamyl) lysine bonds that cross-link substrates such as loricrin
and INV to form the cornified cell envelope, a chemically and
mechanically resistant layer of insoluble protein located under the
plasma membrane (Rice and Green, 1979; Thacher, 1989; Fuchs,
1990). The ultimate consequence of epidermal differentiation is the
formation of the stratum corneum, layers of terminally differentiated
cornified cells in the outermost epidermis, responsible for the barrier
properties of the skin (Downing, 1992).
Manuscript received June 23, 1997; revised October 25, 1997; accepted for
publication December 1, 1997.
Reprint requests to: Dr. Kenneth R. Feingold, Metabolism Service (111F),
Department of Veterans Affairs Medical Center, 4150 Clement Street, San
Francisco, CA 94121.
Abbreviations: CE, cornified envelope; INV, involucrin; PPAR, peroxisome
proliferator-activated receptor; RXR, retinoid X-activated receptor; TG’ase,
transglutaminase.
0022-202X/98/$10.50 · Copyright © 1998 by The Society for Investigative Dermatology, Inc.
368
physiologic doses of the fatty acids oleic acid, linoleic
acid, and eicosatetraynoic acid, which are also activators
of PPARa, also induced involucrin and transglutaminase
protein and mRNA. In contrast, the PPARg ligand prosta-
glandin J2 had no effect on protein or mRNA levels of
involucrin or transglutaminase. Levels of involucrin and
transglutaminase mRNA and protein were induced by
clofibric acid in keratinocytes incubated in 1.2 mM
calcium, a concentration which by itself induces keratino-
cyte differentiation. Finally, PPARa activators inhibit
DNA synthesis. This study demonstrates that PPARa
activators, including putative endogenous ligands such
as fatty acids, induce differentiation and inhibit prolifera-
tion in keratinocytes, and suggests a regulatory role for
the PPARa in epidermal homeostasis. Key word: peroxisome
proliferator-activated receptor. J Invest Dermatol 110:368–375,
1998
Although the specific cellular signals that initiate the changes in
gene expression regulating the different steps of differentiation remain
unknown, calcium has been identified as a key regulator of terminal
differentiation. Keratinocytes incubated in medium containing low
levels of calcium (0.03 mM) remain in a proliferative, relatively
undifferentiated state, whereas keratinocytes maintained in high extra-
cellular calcium concentrations (1.2 mM) express increased levels of
differentiation specific proteins, such as INV and TG’ase (Hennings
et al, 1989; Fuchs, 1990; Dlugosz and Yuspa, 1994). These proteins
are regulated both at the transcriptional and at the translational levels,
and their expression leads to increased rates of cornified envelope (CE)
formation (Hennings et al, 1989; Pillai and Bikle, 1991; Dlugosz and
Yuspa, 1994; Gibson et al, 1996).
Other factors such as 1,25-dihydroxyvitamin D3, the hormonally
active form of vitamin D, have well known effects on keratinocyte
proliferation and differentiation. 1,25-dihydroxyvitamin D3 is a potent
inducer of keratinocyte differentiation, and, like calcium, accelerates
the appearance of several CE precursor proteins, and inhibits cellular
proliferation (Pillai and Bikle, 1991; Itin et al, 1994). Retinoids and
thyroid hormone also affect keratinocyte differentiation, although, in
contrast to vitamin D, they inhibit in vitro differentiation and
cornification and suppress the expression of differentiation-associated
keratins (Isseroff et al, 1989; Blumberg et al, 1992; Fisher and Voorhees,
1996). Though their effects are diverse, vitamin D3, retinoids, and
thyroid hormone are all ligands for nuclear hormone receptors in the
same superfamily, transcription factors that are heterodimeric partners
of the retinoid X-activated receptor (RXR) (Mangelsdorf et al, 1995;
Kastner et al, 1995). Recent studies in utero suggest that one or more
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members of this receptor superfamily may be key regulators of epidermal
development. Overexpression of a truncated inactive RARα in fetal
murine epidermis results in aberrant cutaneous development, most
likely due to subversion of the RXR and its partners (Saitou et al,
1995; Imakado et al, 1995).
The peroxisome proliferator-activated receptors (PPAR) are also
members of the nuclear hormone receptor superfamily. The PPAR
subtypes α, δ, and γ are differentially activated by several fatty acids,
arachidonic acid metabolites, and hypolipidemic drugs such as clofibrate
(Keller et al, 1993; Yu et al, 1995; Forman et al, 1995). Whereas PPARγ
is involved in the regulation of adipocyte differentiation, the α isoform
plays a role in lipid metabolism and homeostasis in the liver and kidney
(reviewed in Schoonjans et al, 1996), tissues that, like epidermis, exhibit
high rates of fatty acid synthesis. We have recently demonstrated that
PPARα activators accelerate the development of the stratum corneum
and the epidermal permeability barrier in full thickness fetal rat skin
explants incubated in serum- and hormone-free media (Hanley et al,
1997a). In this study, we sought to determine whether activators of
PPARα might also alter the rate of human keratinocyte differentiation
in vitro. We report here that activators of PPARα are potent stimulators
of keratinocyte differentiation and inhibitors of proliferation.
MATERIALS AND METHODS
Cell culture Human epidermis was isolated from newborn foreskins by
incubation in dispase, and a suspension of keratinocytes was obtained by
incubation in ethylenediaminotetraacetic acid and subsequent trypsinization, as
described by Gibson et al (1996). The cells were plated in serum-free keratinocyte
growth medium (KGM; Clonetics, San Diego, CA), containing 0.07 mM
calcium, and grown to 60–80% confluence. Cells were then passaged twice
and plated in KGM containing 0.07 mM calcium for 48 h, switched to KGM
containing 0.03 mM calcium for 48 h, then treated with either clofibric acid,
fatty acids, or vehicle [, 0.1% dimethylsulfoxide (DMSO) or , 0.1% ethanol
or , 0.1% ethanol with 0.5% bovine serum albumin], or 1.2 mM calcium
with or without clofibric acid, for 0–48 h. Fatty acids and clofibric acid (Sigma,
St. Louis, MO) were solubilized in ethanol or DMSO. 15-Deoxy-∆12,14-
prostaglandin J2 (Prostaglandin J2) (Cayman, Ann Arbor, MI) was solubilized
in DMSO. Fatty acids were complexed with fatty acid-free bovine serum
albumin (Sigma) immediately prior to the initiation of each experiment, filtered
through a 0.2 µm filter, and added to the culture medium giving a final bovine
serum albumin concentration of 100 µM.
RNA isolation Total RNA was isolated according to the method of
Chomczynski et al (1987). Briefly, cells were lyzed in 4 M guanidine isothiocyan-
ate/25 mM sodium citrate/0.5% sarcosyl/0.1 M β-mercaptoethanol, extracted
with phenol-chloroform, and precipitated with ethanol. RNA pellets were
suspended in sterile, diethyl pyrocarbonate-treated water, and RNA was
quantitated by absorbance at 260 nm using the 260/280 nm ratio as an index
of purity.
Northern blotting and cDNA probes Total RNA (15 µg per sample) was
size fractionated through a 1% agarose gel containing 2.2 M formaldehyde, as
described in Gibson et al (1996). RNA integrity was visualized following
acridine orange staining of the electrophoresed gel. The RNA was transferred
to a nylon membrane that was subsequently baked at 80°C for 2 h. Blots were
then hybridized with the appropriate 32P-labeled probe [P1–2 for INV, a gift
from Dr. Howard Greene (Harvard, Cambridge, MA), and hTG for keratinocyte
transglutaminase 1, a gift from Dr. Robert Rice (UCD, Davis)] overnight at
65°C. Washes were then performed in a solution containing 0.1% sodium
citrate/chloride buffer and 0.1% sodium dodecyl sulfate for 20 min at room
temperature, followed by a 20 min wash at 65°C. Autoradiography was
performed at –70°C. Blots were probed with β-actin to confirm equal loading.
Involucrin and transglutaminase protein levels Protein concentration
was assessed by protein electrophoresis and western blotting, as described in
Gibson et al (1996). Briefly, cells were lyzed in 2% sodium dodecyl sulfate and
the lysate sonicated. Following protein determination [Bicinchoninic acid
protein assay (Pierce, Rockford, IL)], equal amounts of protein were electro-
phoresed on 7.5% polyacrylamide gels and electroblotted onto membranes.
INV protein was detected by incubation overnight at 4°C with a polyclonal
rabbit anti-human INV antibody (a gift from Dr. Robert Rice) (1:1000 in
Tween 20, 0.5%, and nonfat milk, 5%). Densitometry was used to quantitate
INV specific bands on the autoradiograms.
TG’ase protein expression was measured as for INV expression, with
modifications as described in Gibson et al (1996). Briefly, stacking, sample, and
running buffers all contained 4 M urea, and following electrophoresis, gels were
washed in 4 M urea, 25 mM Tris-HCl, pH 7.4, 75 mM NaCl, 0.1 mM
dithiothreitol, and 2 mM ethylenediamine tetraacetic acid for 90 min prior to
electroblotting, allowing TG’ase to be detected by BC.1 primary antibody
(Thacher, 1989).
CE formation The rate of CE formation was determined as described in
Gibson et al (1996). Briefly, cells were incubated with 35S-methionine/cysteine
for 48 h, washed with phosphate-buffered saline, and harvested into 1.1 ml of
2% sodium dodecyl sulfate. Aliquots were reserved for protein determinations.
The remaining cell lysate (1 ml) was sonicated briefly (10 s). One milliliter of
4% sodium dodecyl sulfate/4 mM dithiothreitol was then added, and the
mixture was heated to .95oC for 30 min. Following cooling, sodium dodecyl
sulfate/dithiothreitol-insoluble material was collected on filter discs, washed
with 0.5% sodium dodecyl sulfate/0.5% dithiothreitol, and quantitated by
scintillation spectrophotometry. To determine total protein synthesized during
the 48 h of 35S labeling, a reserved aliquot of the cell lysate (taken prior to
heating) was precipitated with an equal volume of 2% bovine serum albumin
and 1 ml of 10% (wt/vol) trichloroacetic acid on ice for 30 min, and 35S-
labeled precipitated protein was collected onto filter disks, washed with 5%
trichloroacetic acid, and counted in a scintillation counter. Total protein was
determined by the method of Bradford (BioRad, Hercules, CA).
DNA content and synthesis DNA content was measured by the method
of Labarca et al (1980). Briefly, cells were incubated for 2 h with bisbenzimidazole
(Hoechst 33258, 1 mg per ml) and fluorescence measured with a Perkin-Elmer
fluorimeter, excitation 356, emission 458. A standard curve was made using
dilutions of calf thymus DNA.
The rate of DNA synthesis was determined by measuring [3H]thymidine
incorporation into cellular DNA after 4 h of incubation with 2 µCi [3H]thymid-
ine (110 Ci methyl per mmol, 1929-[3H]thymidine, Amersham, Arlington
Heights, IL) per ml media. The radioactivity in the washed trichloroacetic acid
precipitate was quantitated by scintillation spectroscopy.
Statistics Statistical analysis was performed using Student’s t test.
RESULTS
The PPARa activator clofibric acid induces INV and TG’ase
mRNA levels Keratinocytes maintained in low levels of extracellular
calcium remain in a proliferative state, expressing relatively low message
levels of differentiation-specific proteins such as INV and TG’ase (Pillai
and Bikle, 1991; Dlugosz and Yuspa, 1994; Gibson et al, 1996). To
determine whether activators of PPARα induce differentiation in
cultured keratinocytes, we first measured INV and TG’ase mRNA
levels by northern analysis in cultures maintained in low calcium
(0.03 mM), incubated either in the presence of the PPARα activator
clofibric acid or in the vehicle, over a 48 h time period. As shown in
Fig 1, levels of INV and TG’ase mRNA in both clofibric acid treated
and vehicle treated cells progressively increase throughout the 48 h
period; however, clofibric acid treated cells exhibit significantly
increased levels of INV compared with vehicle treated cells at all time
points examined (6, 12, 24, 48 h), and significantly increased TG’ase
mRNA levels at 24 and 48 h (Fig 1), with a maximal effect on INV
at 12–24 h and on TG’ase at 24–48 h (2–7-fold increase over controls
in three separate experiments). β-actin mRNA levels remained constant
over time, and were unaffected by clofibric acid treatment. These
results indicate that the PPARα activator clofibric acid induces two
different markers of keratinocyte differentiation.
To determine whether the effect by clofibric acid on INV and
TG’ase message levels was concentration dependent, we next measured
INV and TG’ase message levels in keratinocytes maintained in 0.03 mM
calcium and incubated in the presence of increasing concentrations of
clofibric acid. As shown in Fig 2, levels of INV and TG’ase mRNA
were significantly increased by 100 µM clofibric acid. Effects of
clofibric acid on mRNA levels of both INV and TG’ase were maximal
with 200–400 µM. Incubation in 500 µM clofibric acid resulted in
toxic effects.
Increased calcium is well known to stimulate keratinocyte differenti-
ation (Hennings et al, 1989; Fuchs, 1990; Pillai and Bikle, 1991;
Dlugosz and Yuspa, 1994; Itin et al, 1994; Gibson et al, 1996).
Therefore, we next compared clofibric acid induced message levels of
INV and TG’ase with levels induced by 1.2 mM extracellular calcium.
mRNA levels of both INV and TG’ase in clofibric acid treated cells
maintained in 0.03 mM calcium for 24 h are similar to levels observed
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Figure 1. Induction of INV and TG’ase mRNA by clofibric acid over
time. Pre-confluent keratinocytes were incubated up to 48 h in KGM
containing 0.03 mM calcium and either vehicle (, 0.1% DMSO) (control) or
200 µM clofibric acid (clo). Fifteen micrograms total RNA was isolated and
subjected to northern hybridization as described in Materials and Methods. A
representative blot is shown here. Data presented in the graphs represent the
average of three independent experiments (three different donors) and are
expressed as mean 6 SEM. *p ø 0.01, n 5 6.
in cells incubated for the same time period in the presence of 1.2 mM
calcium (Fig 3). Similar results were obtained after 48 h of treatment
(data not shown). These data indicate that clofibric acid is a potent
inducer of keratinocyte differentiation, comparable with calcium.
We next determined whether the addition of clofibric acid and high
extracellular calcium together might have additive effects on the
expression of INV or TG’ase mRNA. Figure 4 shows the time course
of INV and TG’ase mRNA induction in cells grown in medium
supplemented with 1.2 mM Ca11 in the presence of clofibric acid or
vehicle control. As has been shown previously (Su et al, 1994), in
keratinocytes incubated in high calcium alone, INV mRNA levels
increase up to 24 h, and then decline by 48 h, in contrast to
keratinocytes maintained in low calcium, in which INV mRNA levels
increase up to 48 h (see Fig 1). TG’ase mRNA levels in cells in high
Figure 2. Clofibric acid effects on INV and TG’ase mRNA levels are
concentration dependent. Preconfluent keratinocytes were incubated 24 h
in KGM containing 0.03 mM calcium and increasing concentrations of clofibric
acid (clo). Northern analysis was performed as described in Materials and Methods.
A representative autoradiograph is shown here. The accompanying graph
represents the average (mean 6 SEM) of three separate experiments. *p ø 0.005,
n 5 6.
calcium increase up to 24 h and either increase modestly or plateau,
as reported previously (Su et al, 1994). Clofibric acid treated cells
exhibit significantly increased mRNA levels of INV at 12, 24, and
48 h compared with high calcium controls (Fig 4). TG’ase levels
increased significantly with clofibric acid treatment compared with
vehicle controls at 24 and 48 h; although increased levels were
sometimes observed at 6 and 12 h, these changes did not reach statistical
significance. Thus, concurrent treatment with the PPARα activator
clofibric acid and 1.2 mM calcium significantly increases mRNA levels
of the differentiation markers INV and TG’ase compared with 1.2 mM
calcium alone.
Fatty acid activators of PPARa also induce INV and TG’ase
message levels We next examined the effects of oleic acid, eicosate-
traynoic acid, and linoleic acid, which, like clofibric acid, also activate
PPARα (Keller et al, 1993; Yu et al, 1995). As shown in Fig 5, oleic
acid (200 µM), eicosatetraynoic acid (25 µM), and linoleic acid (15 µM)
concentrations found maximal in dose response studies (data not shown),
induce INV and TG’ase message levels µ4–10-fold in keratinocytes
maintained in low calcium (0.03 mM). These results demonstrate that
the effects on INV and TG’ase mRNA levels are not specific to
clofibric acid, but are induced by other PPARα activators and imply
that PPARα activation is the common mechanism of action for these
effects. In contrast, the PPARγ ligand 15-deoxy-∆12,14-prostaglandin
J2 (Su et al, 1994) had no effect on INV or TG’ase mRNA levels
(data not shown).
INV and TG’ase protein levels are increased by PPARa
activators To determine whether the increase in mRNA is associated
with changes in protein levels, we next examined protein levels of
INV in keratinocytes incubated in 0.03 mM calcium in the presence
of clofibric acid or vehicle. As shown in Fig 6(a), incubation in
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Figure 3. Clofibric acid induced levels of INV and TG’ase mRNA are
similar to calcium induced levels. Preconfluent keratinocytes were incubated
in the presence of 1.2 mM calcium, 0.03 mM calcium, or 0.03 mM calcium
plus 200 µM clofibric acid (clo) for 24 h and northern analysis performed as
described in Fig. 1. Graphs represent the average of data from two independent
experiments (two different donors). A representative autoradiograph is shown
here. *p ø 0.01, n 5 4.
increasing concentrations of clofibric acid for 24 h resulted in a
progressive increase in INV protein levels (8–12-fold induction by
200–400 µM clofibric acid versus vehicle controls in three separate
experiments). The magnitude of the increase was similar to that
produced by incubation in high (1.2 mM) extracellular calcium
(Fig 6a). Similar results were observed after 48 h of treatment (data
not shown). Clofibric acid also induced a further increase in INV
protein in keratinocytes incubated in high calcium (Fig 6b), i.e., levels
of INV protein in keratinocytes incubated in 1.2 mM calcium plus
clofibric acid were 2-fold higher than in keratinocytes incubated in
1.2 mM calcium plus vehicle only.
Finally, to determine whether other PPARα activators also increased
INV protein levels, we incubated keratinocytes in 0.03 mM calcium
in the absence or presence of oleic or linoleic acid, fatty acid activators
of the PPARα. As shown in Fig 7, both oleic acid (200 µM) and
Figure 4. Time course of INV and TG’ase mRNA induction by clofibric
acid in keratinocytes incubated in 1.2 mM calcium. Pre-confluent
keratinocytes were incubated up to 48 h in KGM containing 1.2 mM calcium
and either vehicle (, 0.1% DMSO) (control) or 200 µM clofibric acid. Fifteen
micrograms total RNA was isolated and subjected to northern hybridization as
described in Materials and Methods. A representative autoradiograph is shown
here. Data presented in the graphs represent the average of three independent
experiments (three different donors) and are expressed as mean 6 SEM.
*p ø 0.005, n 5 6.
linoleic acid (15 µM) also induced INV protein expression. In contrast,
the PPARγ ligand 15-deoxy-∆12,14-prostaglandin J2 (Su et al, 1994)
had no effect on INV protein expression (data not shown).
As has been shown previously by others, TG’ase protein levels were
very low in keratinocytes maintained in 0.03 mM calcium (Gibson
et al, 1996). TG’ase protein levels were increased µ3-fold in cells
incubated in the presence of clofibric acid for 48 h (Fig 8a), and
increased µ3-fold and 2-fold by oleic acid and linoleic acid, respectively
(Fig 8b). These results indicate that PPARα activators induce protein
levels of both INV and TG’ase.
Clofibric acid increases the rate of CE formation An additional,
late marker of epidermal differentiation, CE formation, was assessed in
cells treated for 48 h with clofibric acid in low (0.03 mM) and in high
(1.2 mM) calcium. The results of these studies are shown in Table I
and are expressed as the percentage of the vehicle control value in
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Figure 5. mRNA levels of INV and TG’ase are induced by fatty acid
activators of PPARa. Preconfluent keratinocytes were incubated for 24 h in
KGM containing 0.03 mM calcium and either vehicle alone (control) or
200 µM oleic acid (OA), 25 µM eicosatetraynoic acid (ETYA), or 15 µM
linoleic acid (LA). For comparison cells incubated in 1.2 mM calcium alone
are included. Total RNA was isolated and subjected to northern analysis as
described in Materials and Methods. The average (mean 6 SEM) of data from
two separate experiments (two different donors) is shown here. *p ø 0.005,
n 5 4.
0.03 calcium (equals 100%). A concentration dependent increase in
CE formation is seen with increasing concentrations of clofibric acid,
approaching a 4-fold increase (p , 0.01) with 400 mM clofibric acid
in 0.03 mM calcium. Incubation in high calcium alone resulted in an
almost 5-fold increase in the rate of CE formation. Yet clofibric acid
together with high calcium produced a modest but significant increase
over high calcium alone (59% increase, Table I). Compared with
0.03 mM calcium vehicle, clofibric acid and 1.2 mM calcium resulted
in an approximate 6-fold increase in CE synthesis (Table I). These
data indicate that the PPARα activator clofibric acid increases the rate
Figure 6. Protein levels of INV are increased by clofibric acid.
Preconfluent keratinocytes were incubated for 24 h in KGM containing (a)
0.03 mM calcium and either vehicle alone or 100, 200, or 400 µM clofibric
acid (clo), or 1.2 mM calcium and vehicle alone; or (b) 1.2 mM calcium and
either vehicle or 200 µM clofibric acid (Clo). Western analysis was performed
and autoradiograms were quantitated as described in Materials and Methods.
Representative autoradiograms are shown here. The histogram represents the
average (mean 6 SEM) of data from two separate experiments (two different
donors). *p ø 0.01, n 5 4 (a); *p ø 0.01, n 5 6 (b).
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Figure 7. Fatty acid activators of PPARa induce INV protein levels.
Western blot analysis shows increased levels of INV protein in keratinocytes
incubated in 0.03 mM calcium KGM containing either 200 µM oleic acid
(OA) or 15 µM linoleic acid (LA) compared with keratinocytes incubated in
0.03 mM KGM containing vehicle alone (control). A representative
autoradiogram is shown here. The histogram represents the average (mean
6 SEM) of data from two separate experiments (two different donors).
*p ø 0.005, n 5 4.
of CE formation, and that these effects are additive to the increased
rate of CE formation induced by high calcium alone.
Keratinocyte growth is inhibited by clofibric acid Cells stimu-
lated to differentiate either by increased extracellular calcium or by
1,25 dihydroxyvitamin D3 simultaneously exhibit a decrease in cellular
proliferation (Pillai and Bikle, 1991; Itin et al, 1994). To determine if
cell growth is similarly inhibited by clofibric acid, we next measured
DNA content in keratinocytes incubated for the first 48 h in 0.07 mM
calcium (to ensure adhesion) and then switched to low (0.03 mM)
calcium medium containing either vehicle or varying concentrations
of clofibric acid for the final 48 h. As shown in Table II, DNA
content was decreased in a dose dependent manner, with maximal
inhibition of µ20% obtained with 400 µM clofibric acid. Thus, similar
to other inducers of differentiation such as vitamin D3 and high
calcium, clofibric acid inhibits keratinocyte growth.
We next compared the rate of DNA synthesis in clofibric acid- versus
vehicle-treated keratinocytes. Keratinocytes were plated in 0.07 mM
calcium for 48 h, and then switched for 24 h to low calcium (0.03 mM)
medium containing either vehicle or varying concentrations of clofibric
acid. [3H]Thymidine incorporation into DNA was measured during
the final 4 h of incubation. A concentration dependent decrease in the
rate of DNA synthesis was observed in keratinocytes incubated in the
presence of clofibric acid, with a maximal inhibition of µ40% with
400 µM clofibric acid (Table III). These data indicate that clofibric
acid inhibits keratinocyte proliferation.
DISCUSSION
In this study we describe novel effects on keratinocyte differentiation
produced by activators of the nuclear hormone receptor PPARα.
Clofibric acid is a classical peroxisome proliferator and PPARα activator
(Schoonjans et al, 1996) and has been shown previously to activate
the peroxisome proliferator response element in cultured murine
keratinocytes (Imakado et al, 1995). The rate of CE formation,
an indicator of terminal differentiation, was increased µ3-fold in
Figure 8. TG’ase protein levels are increased by PPARa activators.
Western blot analysis was performed as described in Materials and Methods.
Keratinocytes were incubated in 0.03 mM calcium containing either vehicle
(control), (a) 200 µM clofibric acid (clo), or (b) 200 µM oleic acid (OA) or
15 µM linoleic acid (LA). A representative autoradiogram and accompanying
histogram is shown here. Similar results were obtained in two separate
experiments. *p ø 0.005, n 5 4 (a); *p ø 0.005, n 5 3 (b).
keratinocytes incubated in the presence of clofibric acid. Protein levels
of the CE precursor INV, and the cross-linking enzyme TG’ase,
necessary for CE formation, were also increased by clofibric acid. We
examined INV and TG’ase regulation by clofibric acid at the message
level, and found that mRNA levels of both INV and TG’ase were
markedly increased by clofibric acid. Furthermore, other PPARα
activators, such as linoleic acid, eicosatetraynoic acid, and oleic acid,
fatty acids that activate PPARα as potently as the fibrate family of
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Table I. The rate of CE formation is increased by clofibratea
Clofibrate concentration Rate of CE formation
(µM) (% of control)
0.03 mM calcium 0 100.0 6 12.5
50 110.5 6 14.9
200 338.3 6 26.8*
400 386.8 6 28.7*
1.2 mM calcium 0 100.0 6 15.8
50 94.9 6 10.3
200 131.3 6 12.2**
400 158.9 6 15.5**
aPreconfluent keratinocytes were treated with vehicle or with varying concentrations of
clofibrate for 48 h and 35S-methionine incorporation into detergent and reducing agent
insoluble protein was measured as described in Materials and Methods (average value for
controls, 2192 cpms per mg protein; 400 µM clofibrate-treated, 8549). Results presented
here are expressed as the mean 6 SEM of two independent experiments. *p , 0.01
compared with 0.03 calcium controls; **p , 0.01 compared with 1.2 calcium controls;
n 5 6.
Table II. Clofibrate inhibits keratinocyte growtha
Clofibrate DNA content after 48 h
(µM) (µg per dish) Significance
0 15.5 6 0.9 –
50 14.9 6 1.5 not significant
200 13.8 6 1.1 p , 0.05
400 12.1 6 1.3 p , 0.01
aPreconfluent keratinocytes were incubated in 0.03 mM calcium for 48 h in the presence
of vehicle or varying concentrations of clofibrate. DNA content was determined as
described in Materials and Methods. Results are presented as mean 6 SEM, n 5 3.
Table III. The rate of DNA synthesis is inhibited by
clofibratea
Clofibrate cpms per µg DNA
(µM) (per cent control) Significance
0 100.0 6 11.3 –
50 98.2 6 8.5 not significant
200 79.3 6 10.1 p , 0.01
400 61.3 6 8.4 p , 0.005
aPreconfluent keratinocytes were incubated in 0.03 mM calcium for 24 h in the presence
of vehicle or varying concentrations of clofibrate and [3H]thymidine incorporation was
measured over the final 4 h of incubation as described in Materials and Methods (100%
control 5 5390 cpms per µg DNA). Results are presented as mean 6 SEM, n 5 4.
peroxisomal proliferators (Keller et al, 1993; Yu et al, 1995; Schoonjans
et al, 1996), also significantly increased INV and TG’ase protein
and message levels, whereas the PPARγ ligand 15-Deoxy-∆12,14-
prostaglandin J2 had no effect. In addition, stimulatory effects on INV
and TG’ase protein and message levels by clofibric acid were also
observed in keratinocytes incubated in the presence of physiologic
calcium levels (1.2 mM). Together, these results strongly suggest that
PPARα plays a regulatory role in keratinocyte differentiation.
The nuclear hormone receptor PPARα is a member of the thyroid/
vitamin D/retinoid superfamily of transcription factors that require
heterodimerization with the RXR for optimal DNA binding
(Mangelsdorf and Evans, 1995; Kastner et al, 1995; Mangelsdorf
et al, 1995). Whereas effects by PPARα activators on keratinocyte
differentiation have not been previously reported, it is well known
that activators/ligands of other nuclear hormone receptors in this
superfamily regulate keratinocyte growth and differentiation. For
example, 1,25-dihydroxyvitamin D3 increases intracellular calcium,
promotes terminal differentiation, and inhibits growth of keratinocytes,
evidenced by increased levels of INV and TG’ase mRNA, and increased
CE formation (Smith et al, 1986; Pillai and Bikle, 1991; Su et al, 1994).
Retinoic acid and its analogs, as well as thyroid hormone, also have
well-known effects on the terminal differentiation of keratinocytes,
but in contrast to PPARα activators and 1,25-dihydroxyvitamin
D3, they inhibit cornification in cultured keratinocytes and suppress
expression of differentiation specific keratins via their respective nuclear
receptors (Isseroff et al, 1989; Blumberg et al, 1992; Fisher and Voorhees,
1996). Thus, although their effects are diverse, activators/ligands for
this nuclear hormone receptor superfamily are important modulators
of keratinocyte growth and differentiation. The mechanisms by which
the PPARα activators affect keratinocyte differentiation remain unclear.
For example, it remains to be determined whether PPARα activators
regulate INV and TG’ase gene expression directly.
Studies in vivo also suggest an important role for this superfamily of
nuclear receptors in epidermal formation. Overexpression of an abnor-
mal RARα in fetal murine basal epidermal cells results in thin, fragile
skin (Saitou et al, 1995), whereas overexpression in suprabasal cells
results in a severe skin phenotype characterized by the absence of
mature lamellar membrane structures in the stratum corneum interstices,
leading to impaired barrier function (Imakado et al, 1995). Because the
mutated RARα retains its ability to dimerize and bind DNA, but
the resultant complex is transcriptionally inactive, signaling pathways
dependent on RXR heterodimeric complexes are perturbed. Thus,
the superfamily of nuclear hormone receptors may play an important
role early in the initial differentiation of keratinocytes and later in the
regulation of lipid metabolism crucial to the formation of a functional
epidermal barrier.
Our laboratory has been studying fetal epidermal barrier and stratum
corneum development. Several hormones that interact with receptors
in the nuclear hormone receptor superfamily, such as glucocorticoids,
estrogen, and testosterone, affect epidermal ontogenesis when given in
pharmacologic doses (Aszterbaum et al, 1993; Hanley et al, 1996a, b).
Furthermore, physiologic concentrations of thyroid hormone, as well
as activators of the PPARα and farnesoid X-activated receptor, acceler-
ate the development of the stratum corneum and the epidermal barrier
in fetal skin explants (Hanley et al, 1996a, 1997a); however, it is not
clear which one or more of these factors are required for the final
steps of stratum corneum formation, because development proceeds
normally in fetal rat skin explants incubated in hormone- and serum-
free medium (Hanley et al, 1996a). Moreover, fetal mice made
hypothyroid due to a mutation in the TSH receptor, though exhibiting
a temporary delay in epidermal development prenatally, are born with
apparently normal epidermal barriers (Hanley et al, 1997b). Similarly,
PPARα may not be essential in embryonic development, as mice
lacking PPARα are born viable and fertile, with no obvious cutaneous
defects (Lee et al, 1995). These data suggest functional redundancy
among RXR partners, with a single defect resulting in a mild
phenotype. In contrast, overexpression of a mutated RARα that can
perturb effective dimerization of this family of hormone receptors
results in a dramatic phenotype and demonstrates the central role of
RXR in epidermal development.
PPARα is abundant in liver and kidney where it plays a role in the
regulation of fatty acid metabolism (reviewed in Schoonjans et al,
1996). It is activated by molecules that induce peroxisomal proliferation,
such as the synthetic agents clofibric acid and WY14,643, used for the
therapy of hyperlipidemia, as well as by several free fatty acids (Keller
et al, 1993; Yu et al, 1995; Schoonjans et al, 1996). Because all layers
of the epidermis actively synthesize fatty acids (Feingold, 1991),
significant endogenous levels of these fatty acids are likely to be present
throughout the epidermis. Indeed, the fatty acid concentrations that
induced keratinocyte differentiation in this study (15 µM linoleic acid
or 200 µM oleic acid) are consistent with physiologic concentration
ranges for fatty acids in the epidermis (0.3–2 mM) and with fatty acid
concentrations that activate PPARα in other cell types (Long, 1970;
Lampe et al, 1983; Keller et al, 1993; Yu et al, 1995). Thus, endogenous
fatty acids are potential candidates as key local regulators of keratinocyte
differentiation. It is of interest that glucocorticoids, which accelerate
epidermal barrier development in vivo and in vitro in fetal rats, increase
the expression of PPARα mRNA in other cell types (Lemberger et al,
1994; Steineger et al, 1994). This raises the possibility that the
effect of glucocorticoids on epidermal formation may be mediated
via PPARα.
In summary, we demonstrate here that activators of the nuclear
hormone receptor PPARα, a member of the vitamin D receptor/
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RAR/RXR superfamily of transcription factors, induce keratinocyte
differentiation. These studies, taken together with evidence that PPARα
activators accelerate fetal epidermal maturation, suggest a physiologic
role for PPARα in epidermal homeostasis.
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